OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

HCMV Envelope Glycoprotein Diversity Demystified
Mathilde Foglierini, Jessica Marcandalli, Laurent Perez
Frontiers in Microbiology (2019) Vol. 10
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Antibodies to combat viral infections: development strategies and progress
Giuseppe Pantaleo, Bruno E. Correia, Craig Fenwick, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 9, pp. 676-696
Open Access | Times Cited: 154

Structures of HCMV Trimer reveal the basis for receptor recognition and cell entry
Marc Kschonsak, Lionel Rougé, Christopher P. Arthur, et al.
Cell (2021) Vol. 184, Iss. 5, pp. 1232-1244.e16
Open Access | Times Cited: 43

Genomic and geographical structure of human cytomegalovirus
Oscar Charles, Cristina Venturini, Soren Gantt, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 30
Open Access | Times Cited: 15

Multivalent cytomegalovirus glycoprotein B nucleoside modified mRNA vaccines did not demonstrate a greater antibody breadth
Hsuan-Yuan Wang, Leike Li, Cody S. Nelson, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 5

Functional Profile of Human Cytomegalovirus Genes and Their Associated Diseases: A Review
Lele Ye, Yunyun Qian, Weijie Yu, et al.
Frontiers in Microbiology (2020) Vol. 11
Open Access | Times Cited: 38

Design of a novel and potent multivalent epitope based human cytomegalovirus peptide vaccine: An immunoinformatics approach
Nahid Akhtar, Amit Joshi, Joginder Singh, et al.
Journal of Molecular Liquids (2021) Vol. 335, pp. 116586-116586
Closed Access | Times Cited: 31

Common Polymorphisms in the Glycoproteins of Human Cytomegalovirus and Associated Strain-Specific Immunity
Hsuan-Yuan Wang, Sarah Valencia, Susanne P. Pfeifer, et al.
Viruses (2021) Vol. 13, Iss. 6, pp. 1106-1106
Open Access | Times Cited: 30

Developing a Vaccine Against Human Cytomegalovirus: Identifying and Targeting HCMV’s Immunological Achilles’ Heel
Anastasia Lankina, Marta Brezmes Raposo, Alexander Hargreaves, et al.
Vaccines (2025) Vol. 13, Iss. 5, pp. 435-435
Open Access

Virus-Like Particles and Nanoparticles for Vaccine Development against HCMV
Michela Perotti, Laurent Perez
Viruses (2019) Vol. 12, Iss. 1, pp. 35-35
Open Access | Times Cited: 33

Human Cytomegalovirus Primary Infection and Reactivation: Insights From Virion-Carried Molecules
Yuqing Wang, Xiaosu Zhao
Frontiers in Microbiology (2020) Vol. 11
Open Access | Times Cited: 29

Antiviral Approach to Cytomegalovirus Infection: An Overview of Conventional and Novel Strategies
Paolo Bottino, Lisa Pastrone, Antonio Curtoni, et al.
Microorganisms (2023) Vol. 11, Iss. 10, pp. 2372-2372
Open Access | Times Cited: 10

Rationally designed Human Cytomegalovirus gB nanoparticle vaccine with improved immunogenicity
Michela Perotti, Jessica Marcandalli, Davide Demurtas, et al.
PLoS Pathogens (2020) Vol. 16, Iss. 12, pp. e1009169-e1009169
Open Access | Times Cited: 21

Cell Fusion and Syncytium Formation in Betaherpesvirus Infection
Jiajia Tang, Giada Frascaroli, Xuan Zhou, et al.
Viruses (2021) Vol. 13, Iss. 10, pp. 1973-1973
Open Access | Times Cited: 17

Human cytomegalovirus: pathogenesis, prevention, and treatment
Zifang Shang, Xin Li
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 2

The Human Cytomegalovirus UL116 Glycoprotein Is a Chaperone to Control gH-Based Complexes Levels on Virions
Giacomo Vezzani, Diego Amendola, Dong Yü, et al.
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 12

Recent progress in development of monoclonal antibodies against human cytomegalovirus
Xiaohua Ye, Zhiqiang Ku, Ningyan Zhang, et al.
Current Opinion in Virology (2021) Vol. 52, pp. 166-173
Closed Access | Times Cited: 12

Characterization of Plasma Immunoglobulin G Responses in Elite Neutralizers of Human Cytomegalovirus
Melissa J. Harnois, Maria Dennis, Dagmar Stöhr, et al.
The Journal of Infectious Diseases (2022) Vol. 226, Iss. 9, pp. 1667-1677
Open Access | Times Cited: 8

The Humoral Immune Response Against the gB Vaccine: Lessons Learnt from Protection in Solid Organ Transplantation
Ariane C. Gomes, Paul Griffiths, Matthew B. Reeves
Vaccines (2019) Vol. 7, Iss. 3, pp. 67-67
Open Access | Times Cited: 13

A Virus Genetic System to Analyze the Fusogenicity of Human Cytomegalovirus Glycoprotein B Variants
Xuan Zhou, Giorgia Cimato, Yi‐Hua Zhou, et al.
Viruses (2023) Vol. 15, Iss. 4, pp. 979-979
Open Access | Times Cited: 4

The Pentamer glycoprotein complex inhibits viral Immediate Early transcription during Human Cytomegalovirus infections
Michael Ohman, Emily R. Albright, Christopher B. Gelbmann, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 39
Open Access | Times Cited: 1

A Novel Strain-Specific Neutralizing Epitope on Glycoprotein H of Human Cytomegalovirus
Marco Thomas, Barbara Kropff, Andreá Schneider, et al.
Journal of Virology (2021) Vol. 95, Iss. 18
Open Access | Times Cited: 8

Engineering, decoding and systems-level characterization of chimpanzee cytomegalovirus
Quang Vinh Phan, Boris Bogdanow, Emanuel Wyler, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 1, pp. e1010193-e1010193
Open Access | Times Cited: 5

IgA binds to the AD‐2 epitope of glycoprotein B and neutralizes human cytomegalovirus
Saima Siddiqui, Sarah Hackl, Hamid B. Ghoddusi, et al.
Immunology (2020) Vol. 162, Iss. 3, pp. 314-327
Open Access | Times Cited: 6

Page 1 - Next Page

Scroll to top